Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

101112131415161718

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

27th Mar 2024 11:56

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation. Read More

AstraZeneca treatments become "first and only" to be approved in Japan

27th Mar 2024 09:19

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan. Read More

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

27th Mar 2024 09:03

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week. Read More

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

27th Mar 2024 08:02

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week. Read More

LONDON MARKET MIDDAY: Stocks make tepid start to new week

25th Mar 2024 12:09

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish. Read More

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

25th Mar 2024 09:04

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon. Read More

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

25th Mar 2024 08:40

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults. Read More

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

25th Mar 2024 07:59

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts. Read More

AstraZeneca's Tagrisso successful in treating lung cancer

21st Mar 2024 16:43

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment. Read More

AstraZeneca forks out USD2 billion as buying spree continues

19th Mar 2024 18:39

(Alliance News) - AstraZeneca PLC on Tuesday continued its recent shopping spree, this time announcing a deal worth around USD2 billion to acquire Fusion Pharmaceuticals Inc. Read More

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

19th Mar 2024 08:56

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates. Read More

UK dividends calendar - next 7 days

18th Mar 2024 16:09

Read More

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

18th Mar 2024 14:08

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments. Read More

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

14th Mar 2024 10:01

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline. Read More

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

14th Mar 2024 07:52

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon. Read More

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

8th Mar 2024 06:00

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday. Read More

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

6th Mar 2024 14:40

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday. Read More

AstraZeneca's breast cancer treatment blocked for NHS use in England

5th Mar 2024 14:24

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients. Read More

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

4th Mar 2024 09:31

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer. Read More

AstraZeneca's Voydeya treatment recommended for EU approval

26th Feb 2024 08:51

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment. Read More

101112131415161718
FTSE 100 Latest
Value8,275.66
Change0.00